In cultured SH-SY5Y human neuroblastoma cells, liraglutide pretreatment significantly reduced oxidative stress and promoted neuronal survival and differentiation, largely through activation of the PI3K-Akt or Akt-STAT3 signaling pathway [83,84]. Here, AKT1 is linked to neuroblastoma.